Back to search
FDAFDA · Food and drugs·Recall number D-0489-2025

DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62

Published July 2, 2025 · Recall initiated: May 28, 2025

Summary

FDA records drug Class II recall D-0489-2025, published July 2, 2025 and initiated May 28, 2025. Recalling firm: Pfizer Inc.; Status: Ongoing; Reported quantity: 98,410 vials; Lot: Lot KA5023, exp 02/28/2026. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Discoloration; discolored solution from cracked vials

What to do

Voluntary: Firm initiated · Letter

Get an email if DOBUTAMINE has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
DOBUTAMINE
Manufacturer
Pfizer Inc.
Distributor
Nationwide in the USA
Lot
Lot KA5023, exp 02/28/2026
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was DOBUTamine Injection, USP, 250 mg/20 mL (12.5 mg/mL), 20 mL per Single-dose Vial, carton of 10 Fliptop Vials, Rx only, For Intravenous Use Only, Made in Italy, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA. NDC Carton: 0409-2344-02; NDC Vial: 0409-2344-62 recalled?

Yes. FDA published recall D-0489-2025 on July 2, 2025. Reported hazard: Discoloration; discolored solution from cracked vials

What should I do if I have this product?

Voluntary: Firm initiated · Letter

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: DOBUTAMINE.